Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: Evidence from an updated meta-analysis based on 17 case-control studies

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 6, 2014, Pages 873-881

  Li, Cuiping ^a   Zhou, Yang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Acute lymphoblastic leukemia; ALL; Meta analysis; NQO1 C609T polymorphism

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GROUPS BY AGE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SYSTEMATIC REVIEW;

ADULT; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; META-ANALYSIS AS TOPIC; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 84901327911     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1595-5     Document Type: Review

References (50)

1. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088-1101
2. Belinsky M, Jaiswal AK (1993) NAD(P)H: quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 12(2):103-117 (Pubitemid 23220675)
3. Bolufer P, Barragan E, Collado M, Cervera J, Lopez JA, Sanz MA (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30(12):1471-1491. doi:10.1016/j.leukres.2006.01. 016 (Pubitemid 44573473)
4. Bolufer P, Collado M, Barragan E, Cervera J, Calasanz MJ, Colomer D, Roman-Gomez J, Sanz MA (2007) The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 92(3):308-314 (Pubitemid 350143539)
5. Canalle R, Burim RV, Tone LG, Takahashi CS (2004) Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 43(2):100-109. doi:10.1002/em.20003 (Pubitemid 38332725)
6. Chan JY, Ugrasena DG, Lum DW, Lu Y, Yeoh AE (2011) Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol 29(3):116-123. doi:10.1002/hon.965
7. Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M (2006) NAD(P)H: quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(5):979-987. doi:10.1158/1055-9965.EPI-05-0899 (Pubitemid 43823527)
8. Chen H, Lum A, Seifried A, Wilkens LR, Le Marchand L (1999) Association of the NAD(P)H: quinone oxidoreductase 609C- > T polymorphism with a decreased lung cancer risk. Cancer Res 59(13):3045-3048 (Pubitemid 29315998)
9. Cho CG, Lee SK, Nam SY, Lee MS, Lee SW, Choi EK, Park HJ, Kim SY (2006) Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk. J Korean Med Sci 21(6):1075-1079
10. Clavel J, Bellec S, Rebouissou S, Menegaux F, Feunteun J, Bonaiti-Pellie C, Baruchel A, Kebaili K, Lambilliotte A, Leverger G, Sommelet D, Lescoeur B, Beaune P, Hemon D, Loriot MA (2005) Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev 14(6):531-540 (Pubitemid 41689653)
11. Cochran WG (1950) The comparison of percentages in matched samples. Biometrika 37(3-4):256-266
12. de Aguiar Goncalves BA, Vasconcelos GM, Thuler LC, Andrade C, Faro A, Pombo-de-Oliveira MS, Emerenciano M, de Camargo B, Bernstain L, Neves CC, Agareno JM, de Carvalho LM, Araujo FN, de Brito NP, Magalhaes IQ, Cordoba JC, Pimenta F, Gadelha A, Cartaxo E, Basegio RM, Mnayarji A, Souza MS, Arencibia A, Melaragno R, Coser VM, Lafayete TC, Koifman S (2012) NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55 M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution. Cancer Causes Control 23(11):1811-1819. doi:10.1007/s10552-012-0060-5
13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188 (Pubitemid 17189972)
14. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634 (Pubitemid 27387172)
15. Farhad Z, Safaei A, Nasiri N, Abdollahzadeh M, Pazhakh V (2012) The Association of NAD(P)H: quinine oxidoreductase gene polymorphisms with pediatric acute lymphoblastic leukemia. Science 43(6):256-261
16. Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA (2008) NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol 168(11):1221-1232. doi:10.1093/aje/kwn246
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560. doi:10.1136/bmj.327.7414. 557 (Pubitemid 37088507)
18. Infante-Rivard C, Vermunt JK, Weinberg CR (2007) Excess transmission of the NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia. Am J Epidemiol 165(11):1248-1254. doi:10.1093/aje/kwm022 (Pubitemid 47234330)
19. Jia MF, Xi YM, Shi XE, Zhang H, Deng W, Li M, Li P, Xu JW, Ma HZ, Yao XJ (2012) Relationship of MPO and NQO1 gene polymorphisms with susceptibility to acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 20(6):1336-1340
20. Kracht T, Schrappe M, Strehl S, Reiter A, Elsner HA, Trka J, Cario G, Viehmann S, Harbott J, Borkhardt A, Metzler M, Langer T, Repp R, Marschalek R, Welte K, Haas OA, Stanulla M (2004) NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematologica 89(12):1492-1497 (Pubitemid 39643517)
21. Krajinovic M, Labuda D, Sinnett D (2001) Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome. Rev Environ Health 16(4):263-279 (Pubitemid 34453326)
22. Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D (2002) Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 97(2):230-236 (Pubitemid 34019960)
23. Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM (1995) Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer 72(3):555-561
24. Lanciotti M, Dufour C, Corral L, Di Michele P, Pigullo S, De Rossi G, Basso G, Leszl A, Luciani M, Lo Nigro L, Micalizzi C, Valsecchi MG, Biondi A, Haupt R (2005) Genetic polymorphism of NAD(P) H: quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia 19(2):214-216. doi:10.1038/sj.leu.2403613 (Pubitemid 40220584)
25. Larfors G, Hallbook H, Simonsson B (2012) Parental age, family size, and offspring's risk of childhood and adult acute leukemia. Cancer Epidemiol Biomarkers Prev 21(7):1185-1190. doi:10.1158/1055-9965.EPI-12-0178
26. Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT (1999) Prevalence of the inactivating 609C- > T polymorphism in the NAD(P)H: quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 94(2):803-807 (Pubitemid 29323895)
27. Li H, Hao X, Zhang W, Wei Q, Chen K (2008) The hOGG1 Ser-326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(7):1739-1745. doi:10.1158/1055-9965.EPI-08-0001
28. MacArthur AC, McBride ML, Spinelli JJ, Tamaro S, Gallagher RP, Theriault G (2008) Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study. Cancer Causes Control 19(3):283-295. doi:10.1007/s10552-007-9091-8
29. Moran JL, Siegel D, Ross D (1999) A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H: quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci U S A 96(14):8150-8155 (Pubitemid 29328423)
30. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG (2002) NAD(P)H: quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 4(2):62-70. doi:10.109700125817-200203000-00003
31. Ouerhani S, Cherif N, Bahri I, Safra I, Menif S, Abbes S (2013) Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population. Mol Biol Rep 40(2):1307-1314. doi:10.1007/s11033-012-2174-y
32. Perera FP (1997) Environment and cancer: who are susceptible? Science 278(5340):1068-1073
33. Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ, Jaiswal AK (1998) Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 273(13):7382-7389 (Pubitemid 28152759)
34. Rimando M, Yuson ED, de Castro-Bernas G, Okamoto T (2008) Prevalence of GSTT1, GSTM1 and NQO1(609C > T) in filipino children with ALL(acute lymphoblastic leukaemia). Biosci Rep 28(3):117-124
35. Sameer AS, Shah ZA, Syeed N, Rasool R, Afroze D, Siddiqi MA (2010) NAD(P)H: quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev 11(1):209-213
36. Schulz WA, Krummeck A, Rosinger I, Eickelmann P, Neuhaus C, Ebert T, Schmitz-Drager BJ, Sies H (1997) Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics 7(3):235-239 (Pubitemid 27290637)
37. Shields PG, Harris CC (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18(11):2309-2315 (Pubitemid 30350224)
38. Siegel D, Ryder J, Ross D (2001) NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells. Toxicol Lett 125(1-3):93-98 (Pubitemid 33043759)
39. Silveira Vda S, Canalle R, Scrideli CA, Queiroz RG, Tone LG (2010) Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ Mol Mutagen 51(1):48-56. doi:10.1002/em.20510
40. Sirma S, Agaoglu L, Yildiz I, Cayli D, Horgusluoglu E, Anak S, Yuksel L, Unuvar A, Celkan T, Apak H, Karakas Z, Devecioglu O, Ozbek U (2004) NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr Blood Cancer 43(5):568-570. doi:10.1002/pbc. 20098 (Pubitemid 39313956)
41. Smith MT (1999) Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci U S A 96(14):7624-7626
42. Smith MT, Wang Y, Kane E, Rollinson S, Wiemels JL, Roman E, Roddam P, Cartwright R, Morgan G (2001) Low NAD(P) H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. Blood 97(5):1422-1426 (Pubitemid 32183768)
43. Spector TD, Thompson SG (1991) The potential and limitations of meta-analysis. J Epidemiol Community Health 45(2):89-92
44. Strange RC, Spiteri MA, Ramachandran S, Fryer AA (2001) Glutathione-S-transferase family of enzymes. Mutat Res 482(1-2):21-26 (Pubitemid 32787078)
45. Strassburg A, Strassburg CP, Manns MP, Tukey RH (2002) Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH: quinone oxidoreductase in human hepatocellular and biliary tissue. Mol Pharmacol 61(2):320-325 (Pubitemid 34112806)
46. Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D, Gibson NW (1992) NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 52(4):797-802
47. Vijayakrishnan J, Houlston RS (2010) Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 95(8):1405-1414. doi:10.3324/haematol.2010.022095
48. Yamaguti GG, Lourenco GJ, Silveira VS, Tone LG, Lopes LF, Lima CS (2010) Increased risk for acute lymphoblastic leukemia in children with cytochrome P450A1 (CYP1A1)- and NAD(P)H: quinone oxidoreductase 1 (NQO1)-inherited gene variants. Acta Haematol 124(3):182-184. doi:10.1159/000320275
49. Yeoh AE, Lu Y, Chan JY, Chan YH, Ariffin H, Kham SK, Quah TC (2010) Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res 34(3):276-283. doi:10.1016/j.leukres.2009.07.003
50. Zhang ZQ, Yang L, Zhang Y, Yang YH, Nie L, Li L, Wang JX, Zhu XF, Xiao ZJ (2009) Relationship between NQO1C(609T), RAD51(G135C), XRCC3(C241T) single nucleotide polymorphisms and acute lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17(3):523-528